Novartis news

Glivec® approved in EU as first post-surgery therapy to reduce risk of cancer returning in patients with aggressive gastrointestinal tumors

FDA approves Exforge HCT® - the only high blood pressure treatment to combine three medications in a single pill

Novartis investigational adjuvanted (MF59) pre-pandemic avian influenza vaccine Aflunov® shows long lasting, broadly cross-protective immune response

New data presented at American Academy of Neurology congress show 80-83% of MS patients on oral FTY720 were relapse-free for one year - significantly better than a leading current treatment

Pharmaceuticals delivers strong underlying growth in first quarter of 2009 as Novartis continues to rejuvenate product portfolio

Coartem® receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US

Novartis makes an open offer to increase stake in Novartis India Ltd.

Novartis News Feed

Latest News from Novartis International AG

Syndicate content